###begin article-title 0
###xml 132 140 <span type="species:ncbi:9606">Children</span>
Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
###end article-title 0
###begin p 1
Conceived and designed the experiments: FEL NT ROO SK SL CCJ WCL KCK. Performed the experiments: FEL EIL NR. Analyzed the data: FEL MH CCJ. Contributed reagents/materials/analysis tools: NT ROO SK SL CCJ. Wrote the paper: FEL MH CCJ WCL KCK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 64 85 64 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 64 85 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goal of developing a clinically informative prognostic test for severe malaria.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 232 245 232 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 232 245 <span type="species:ncbi:5833">P. falciparum</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">children</span>
###xml 728 736 <span type="species:ncbi:9606">children</span>
###xml 862 870 <span type="species:ncbi:9606">patients</span>
###xml 1066 1074 <span type="species:ncbi:9606">children</span>
###xml 1336 1344 <span type="species:ncbi:9606">children</span>
Based on the hypothesis that endothelial activation and blood-brain-barrier dysfunction contribute to CM pathogenesis, we examined the endothelial regulators, angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2), in serum samples from P. falciparum-infected patients with uncomplicated malaria (UM) or CM, from two diverse populations - Thai adults and Ugandan children. Angiopoietin levels were compared to tumour necrosis factor (TNF). In both populations, ANG-1 levels were significantly decreased and ANG-2 levels were significantly increased in CM versus UM and healthy controls (p<0.001). TNF was significantly elevated in CM in the Thai adult population (p<0.001), but did not discriminate well between CM and UM in African children. Receiver operating characteristic curve analysis showed that ANG-1 and the ratio of ANG-2:ANG-1 accurately discriminated CM patients from UM in both populations. Applied as a diagnostic test, ANG-1 had a sensitivity and specificity of 100% for distinguishing CM from UM in Thai adults and 70% and 75%, respectively, for Ugandan children. Across both populations the likelihood ratio of CM given a positive test (ANG-1<15 ng/mL) was 4.1 (2.7-6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20-0.42). Moreover, low ANG-1 levels at presentation predicted subsequent mortality in children with CM (p = 0.027).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
ANG-1 and the ANG-2/1 ratio are promising clinically informative biomarkers for CM. Additional studies should address their utility as prognostic biomarkers and potential therapeutic targets in severe malaria.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 34 55 34 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 230 233 230 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kain1">[2]</xref>
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Newton1">[3]</xref>
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Snow1">[4]</xref>
###xml 434 437 434 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-DzeingElla1">[5]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Idro1">[6]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Jaffar1">[7]</xref>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Marsh1">[8]</xref>
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
Although greater than 500 million Plasmodium falciparum malaria infections are estimated to occur each year, only a small proportion of patients progress to severe and potentially fatal complications such as cerebral malaria (CM) [1], [2], [3], [4]. However, the mechanisms underlying CM are poorly understood, and limited prognostic tools are available to determine which infected individuals will progress to cerebral complications [5], [6], [7], [8].
###end p 9
###begin p 10
###xml 543 546 543 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Akanmori1">[9]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Grau1">[10]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kern1">[11]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kwiatkowski1">[12]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Lyke1">[13]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Tchinda1">[14]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Grau1">[10]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kern1">[11]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Gimenez1">[15]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner1">[16]</xref>
The discovery of a reliable laboratory test that accurately identifies individuals with, or at risk of, CM would be valuable. The capacity for early detection and intervention in cases of severe malaria and CM would have clinical and economic impact, particularly in resource-poor settings where effective allocation of limited health resources is essential. Several studies have examined the correlation of serum markers, such as cytokines, with severe and complicated malaria. Elevated levels of TNF have been associated with severe malaria [9], [10], [11], [12], [13], [14] and were identified as a predictor of mortality in CM [10], [11]. However, other studies have challenged these findings and reported that TNF levels do not correlate with disease severity [15], [16].
###end p 10
###begin p 11
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner2">[17]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Tchinda1">[14]</xref>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner1">[16]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Combes1">[18]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hollestelle1">[19]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Jakobsen1">[20]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-deMast1">[21]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner1">[16]</xref>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner1">[16]</xref>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Combes1">[18]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hollestelle1">[19]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Jakobsen1">[20]</xref>
Endothelial cell activation and dysfunction have been implicated in the pathogenesis of CM, in which the endothelium responds to parasite-induced inflammation and mediates parasitized erythrocyte sequestration, especially in vital organs such as the brain [17]. Endothelial activation markers, such as endothelial microparticles, vonWillebrand factor and soluble cell-adhesion molecules (sCAMs), including soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1, are increased in malaria and have been positively correlated with disease severity [14], [16], [18], [19], [20], [21]. However the role of sCAMs in the pathophysiology of malaria is unclear, and circulating levels of sCAMs may not accurately reflect expression in vascular beds [16]. Furthermore, it is unclear whether these markers are useful in predicting disease progression or outcome [16], [18], [19], [20].
###end p 11
###begin p 12
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Brown1">[22]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Brown2">[23]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hunt1">[24]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Medana1">[25]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Tripathi1">[26]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Fiedler1">[27]</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Fiedler1">[27]</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Parikh1">[28]</xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Fiedler1">[27]</xref>
###xml 1013 1017 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Parikh1">[28]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Parikh1">[28]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Giuliano1">[29]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Orfanos1">[30]</xref>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-vanderHeijden1">[31]</xref>
###xml 1077 1085 <span type="species:ncbi:9606">patients</span>
In addition to systemic endothelial activation, recent work has focused on mechanisms by which malaria may compromise the structural and functional integrity of the blood-brain-barrier (BBB), leading to leakage of plasma proteins, perivascular edema and neuronal injury [22], [23], [24], [25], [26]. Angiopoietins, a recently described distinct family of angiogenic proteins, have recently been shown to play fundamental physiological roles in maintenance of vascular integrity. Angiopoietin-1 (ANG-1) is constitutively expressed and acts to maintain vascular quiescence [27]. The ANG-1 stabilizing effect is antagonized by angiopoietin-2 (ANG-2), which primes the endothelial activation response and promotes vascular permeability [27], [28]. In healthy individuals, serum ANG-1 levels are normally high, while serum ANG-2 levels are low. Consequently, an increase in ANG-2, or a dysregulation of the ANG-1/2 balance, may be associated with disease states that cause inflammation and vascular permeability [27], [28]. Specifically, elevated ANG-2 levels have been reported in patients with severe sepsis and may contribute to sepsis-related vascular leak [28], [29], [30], [31].
###end p 12
###begin p 13
###xml 344 352 <span type="species:ncbi:9606">children</span>
Based on the hypothesis that dysregulation of angiopoietins may be associated with endothelial and BBB dysfunction during malaria infection, we examined whether both ANG-1 and ANG-2 were clinically informative biomarkers for cerebral malaria. We report that angiopoietin levels were accurate biomarkers of CM and predicted mortality in African children.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Thai Study population
###end title 15
###begin p 16
###xml 407 420 405 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 669 676 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t001">Table 1</xref>
###xml 745 758 743 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 832 835 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 855 868 853 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 970 973 966 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
###xml 407 420 <span type="species:ncbi:5833">P. falciparum</span>
###xml 679 687 <span type="species:ncbi:9606">Patients</span>
###xml 745 758 <span type="species:ncbi:5833">P. falciparum</span>
###xml 855 868 <span type="species:ncbi:5833">P. falciparum</span>
Individuals (>/=13 years of age) admitted to the Hospital for Tropical Disease (Mahidol University, Thailand) for ongoing studies of anti-malarial drug efficacy were eligible for enrolment. The institutional review board of Mahidol University approved the study, and written informed consent was obtained from all patients or their legal guardians. Venous blood samples were collected from 50 patients with P. falciparum malaria (25 consecutive cases of UM and 25 consecutive cases of CM) prior to the initiation of standard anti-malarial therapy, and from 10 healthy controls who had negative blood smears and no history of malaria infection in the previous 6 months (Table 1). Patients with UM were defined based on a positive blood smear for P. falciparum without evidence for severe or complicated malaria as defined by the WHO [1]. CM was defined as P. falciparum infection on blood smear, unrousable coma (Glasgow coma scale </=8) not attributable to other causes [1].
###end p 16
###begin title 17
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
###xml 164 166 <span type="species:ncbi:9606">UM</span>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 199 201 <span type="species:ncbi:9606">CM</span>
Demographic information for adult malaria patients from Thailand and pediatric malaria patients from Uganda; healthy controls (HC), uncomplicated malaria patients (UM) and cerebral malaria patients (CM).
###end title 17
###begin p 18
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 72 78 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 89 91 <span type="species:ncbi:9606">UM</span>
Age and parasitemia are presented as median (range). *p<0.05 vs. HC and daggerp<0.05 vs. UM (Kruskal-Wallis test with Dunn's multiple comparison post-test).
###end p 18
###begin title 19
Ugandan Study population
###end title 19
###begin p 20
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-John1">[32]</xref>
###xml 413 426 413 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 591 594 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 760 773 756 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1137 1144 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t001">Table 1</xref>
###xml 263 275 <span type="species:ncbi:9606">participants</span>
###xml 286 294 <span type="species:ncbi:9606">children</span>
###xml 378 380 <span type="species:ncbi:9606">UM</span>
###xml 409 411 <span type="species:ncbi:9606">CM</span>
###xml 413 426 <span type="species:ncbi:5833">P. falciparum</span>
###xml 665 673 <span type="species:ncbi:9606">Children</span>
###xml 698 700 <span type="species:ncbi:9606">UM</span>
###xml 760 773 <span type="species:ncbi:5833">P. falciparum</span>
###xml 923 931 <span type="species:ncbi:9606">children</span>
###xml 937 939 <span type="species:ncbi:9606">CM</span>
###xml 1174 1182 <span type="species:ncbi:9606">patients</span>
The Ugandan study population has been previously described [32]. The institutional review board at Makerere University, Faculty of Medicine (Kampala, Uganda) granted ethics approval and written informed consent was obtained from the parents or guardians of study participants. Briefly, children 4-12 years old admitted to Mulago Hospital were eligible for enrolment if they had UM or met the WHO criteria for CM: P. falciparum on blood smear and coma (Blantyre coma scale </=2 or Glasgow coma scale </=8) not attributable to hypoglycemia, convulsions, meningitis or other identifiable cause [1]. Lumbar punctures were performed to rule out meningitis/encephalitis. Children were considered to have UM if they had fever (or a history of fever within 24 hours), P. falciparum infection on blood smear, but no evidence of severe or complicated malaria (1). Healthy controls were recruited from the extended household areas of children with CM or uncomplicated malaria and were determined to be healthy by medical history (with no malaria history for the previous 6 months), physical examination and microscopic examination of blood smears (Table 1). Blood samples from malaria patients were drawn prior to the initiation of standard anti-malarial therapy.
###end p 20
###begin p 21
###xml 873 877 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-John1">[32]</xref>
###xml 81 88 <span type="species:ncbi:9606">patient</span>
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 837 845 <span type="species:ncbi:9606">children</span>
Sample handling and quantification of serum biomarker levels: Serum derived from patient blood was immediately frozen, shipped on dry ice, and maintained at -80degreesC until use. The serum used was thawed (on ice) and re-frozen a maximum of 3 times. Serum concentrations of ANG-1, ANG-2 and TNF were measured by ELISA (R&D Systems, Minneapolis MN; TNF: eBioscience, San Diego CA). Concentrations were interpolated from 4-parameter-fit standard curves generated using a standard curve of recombinant human proteins. The upper and lower limits of detection for each assay were as follows: ANG-1 (10,000-156.25 pg/ml), ANG-2 (3,500-54.69 pg/ml) and TNF (500-7.8 pg/ml). Samples were diluted between 1:2 to 1:50 in assay diluent to fall within the range of the standard curves, as per the manufacturers' instructions. TNF levels in Ugandan children were measured as described [32].
###end p 21
###begin title 22
Statistical Analysis
###end title 22
###begin p 23
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 681 683 <span type="species:ncbi:9606">CM</span>
###xml 687 689 <span type="species:ncbi:9606">UM</span>
Statistical analysis was performed using GraphPad Prism v4.03 (San Diego, CA). Serum protein levels were analyzed using a Kruskal-Wallis test, followed by Dunn's multiple comparison tests. Receiver operating characteristic (ROC) curves and area under the ROC curves were generated using (SPSS 16.0. Cutoff values were derived mathematically from the ROC curves, using the point on the ROC curve with the lowest value for the formula: (1-sensitivity)2+(1-specificity)2. Angiopoietin levels and survival outcomes were analyzed using the Wilcoxon rank-sum test. Multivariable logistic regression modeling was used to examine the independent predictive value of biomarkers on outcome (CM vs.UM) in order to account for potential confounding effects of multiple covariates (SPSS 16.0). Hosmer Lemeshow test was used to verify model goodness of fit.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
ANG-1 levels are decreased and ANG-2 levels increased in the serum of cerebral malaria patients compared to uncomplicated patients and healthy controls
###end title 25
###begin p 26
###xml 182 191 182 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1A</xref>
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1A</xref>
###xml 595 604 595 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1A</xref>
###xml 927 936 927 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1A</xref>
###xml 72 74 <span type="species:ncbi:9606">CM</span>
###xml 106 108 <span type="species:ncbi:9606">UM</span>
###xml 149 151 <span type="species:ncbi:9606">UM</span>
###xml 292 294 <span type="species:ncbi:9606">CM</span>
###xml 319 321 <span type="species:ncbi:9606">UM</span>
###xml 369 371 <span type="species:ncbi:9606">UM</span>
###xml 502 509 <span type="species:ncbi:9606">patient</span>
###xml 591 593 <span type="species:ncbi:9606">UM</span>
###xml 681 683 <span type="species:ncbi:9606">UM</span>
###xml 700 702 <span type="species:ncbi:9606">CM</span>
###xml 779 781 <span type="species:ncbi:9606">CM</span>
###xml 869 871 <span type="species:ncbi:9606">CM</span>
###xml 903 905 <span type="species:ncbi:9606">UM</span>
In Thailand, serum ANG-1 levels were significantly lower in adults with CM compared to either adults with UM or healthy controls, and in adults with UM compared to healthy controls (Figure 1A; Kruskal-Wallis: p<0.001). Moreover, serum ANG-2 levels were significantly increased in adults with CM compared to adults with UM or healthy controls, as well as in adults with UM compared to healthy controls (Figure 1A; Kruskal-Wallis: P<0.001). As an additional measure, the ratio of ANG-2 to ANG-1 for each patient was found to be significantly different between healthy controls and adults with UM (Figure 1A; Kruskal-Wallis: p<0.05) and between either healthy controls or adults with UM and adults with CM (p<0.001). To compare these novel biomarkers to an established biomarker of CM, serum TNF levels were also determined. TNF was significantly increased in adults with CM compared to either adults with UM or healthy controls (Figure 1A; Kruskal-Wallis: p<0.001). However, absolute levels of TNF were very low, requiring larger sample volumes to detect.
###end p 26
###begin title 27
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Comparison of angiopoeitin-1 and -2 levels with TNF in adult malaria patients from Thailand.
###end title 27
###begin p 28
###xml 248 250 <span type="species:ncbi:9606">UM</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 302 304 <span type="species:ncbi:9606">CM</span>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
###xml 412 414 <span type="species:ncbi:9606">CM</span>
###xml 420 422 <span type="species:ncbi:9606">UM</span>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
A. Serum concentrations of angiopoietin-1 (ANG-1), angiopoietin-2 (ANG-2), the ratio of ANG-2:ANG-1 (RATIO, expressed as log base 10) and tumour necrosis factor (TNF) were measured in 10 healthy controls (HC), 25 consecutive uncomplicated malaria (UM) patients, and in consecutive 25 cerebral malaria (CM) patients. B. Receiver operating characteristic curves (blue line) were generated for each test to compare CM with UM patients, with the null hypothesis (green line) that area under the curve equals 0.5.
###end p 28
###begin p 29
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Newton1">[3]</xref>
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Marsh1">[8]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Turner1">[16]</xref>
###xml 569 578 569 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2A</xref>
###xml 732 741 732 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2A</xref>
###xml 1040 1049 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2A</xref>
###xml 1190 1199 1190 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2A</xref>
###xml 46 48 <span type="species:ncbi:9606">CM</span>
###xml 79 87 <span type="species:ncbi:9606">children</span>
###xml 131 138 <span type="species:ncbi:9606">patient</span>
###xml 267 269 <span type="species:ncbi:9606">CM</span>
###xml 321 329 <span type="species:ncbi:9606">children</span>
###xml 431 439 <span type="species:ncbi:9606">children</span>
###xml 445 447 <span type="species:ncbi:9606">CM</span>
###xml 468 476 <span type="species:ncbi:9606">children</span>
###xml 482 484 <span type="species:ncbi:9606">UM</span>
###xml 522 530 <span type="species:ncbi:9606">children</span>
###xml 536 538 <span type="species:ncbi:9606">UM</span>
###xml 664 672 <span type="species:ncbi:9606">children</span>
###xml 678 680 <span type="species:ncbi:9606">CM</span>
###xml 693 701 <span type="species:ncbi:9606">children</span>
###xml 707 709 <span type="species:ncbi:9606">UM</span>
###xml 781 789 <span type="species:ncbi:9606">children</span>
###xml 795 797 <span type="species:ncbi:9606">UM</span>
###xml 920 928 <span type="species:ncbi:9606">children</span>
###xml 934 936 <span type="species:ncbi:9606">CM</span>
###xml 945 953 <span type="species:ncbi:9606">children</span>
###xml 959 961 <span type="species:ncbi:9606">UM</span>
###xml 991 999 <span type="species:ncbi:9606">children</span>
###xml 1005 1007 <span type="species:ncbi:9606">UM</span>
###xml 1151 1159 <span type="species:ncbi:9606">children</span>
###xml 1165 1167 <span type="species:ncbi:9606">UM</span>
###xml 1172 1180 <span type="species:ncbi:9606">children</span>
###xml 1186 1188 <span type="species:ncbi:9606">CM</span>
###xml 1292 1300 <span type="species:ncbi:9606">children</span>
###xml 1306 1308 <span type="species:ncbi:9606">CM</span>
###xml 1313 1321 <span type="species:ncbi:9606">children</span>
###xml 1327 1329 <span type="species:ncbi:9606">UM</span>
The manifestations and outcomes of severe and CM may differ between adults and children and between varying genetic backgrounds of patient and parasite populations [1], [3], [8], [16]. Therefore, the hypothesis that angiopoietin levels are informative biomarkers for CM was further examined in a larger cohort of African children. Similar to the observations in Thailand, serum ANG-1 levels were significantly decreased in Ugandan children with CM compared to Ugandan children with UM and healthy controls, and in Ugandan children with UM compared to healthy controls (Figure 2A; Kruskal-Wallis: p<0.001). Additionally, ANG-2 levels were significantly elevated in children with CM compared to children with UM and healthy controls (Figure 2A; Kruskal-Wallis: p<0.001), and between children with UM and healthy controls (p<0.01). Furthermore, as in the adult population, the ANG-2:ANG-1 ratio was significantly higher in children with CM than in children with UM and healthy controls, and in children with UM compared with healthy controls (Figure 2A; Kruskal-Wallis: p<0.001). While TNF levels were significantly lower in healthy controls compared to children with UM and children with CM (Figure 2A; Kruskal-Wallis: p<0.001), there was no significance difference in serum TNF values between children with CM and children with UM.
###end p 29
###begin title 30
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Comparison of angiopoietin-1 and -2 with TNF in pediatric malaria patients from Uganda.
###end title 30
###begin p 31
###xml 237 239 <span type="species:ncbi:9606">UM</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 279 281 <span type="species:ncbi:9606">CM</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 389 391 <span type="species:ncbi:9606">CM</span>
###xml 397 399 <span type="species:ncbi:9606">UM</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
A. Serum concentrations of angiopoietin-1 (ANG-1), angiopoietin-2 (ANG-2), the ratio of ANG-2:ANG-1 (RATIO, expressed as log base 10), and tumour necrosis factor (TNF) were measured in 28 healthy controls (HC), 67 uncomplicated malaria (UM) patients, and in 69 cerebral malaria (CM) patients. B. Receiver operating characteristic curves (blue line) were generated for each test to compare CM with UM patients, with the null hypothesis (green line) that area under the curve equals 0.5.
###end p 31
###begin p 32
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t002">Table 2</xref>
###xml 170 172 <span type="species:ncbi:9606">CM</span>
###xml 174 176 <span type="species:ncbi:9606">UM</span>
###xml 371 379 <span type="species:ncbi:9606">children</span>
###xml 385 387 <span type="species:ncbi:9606">UM</span>
###xml 400 408 <span type="species:ncbi:9606">children</span>
###xml 414 416 <span type="species:ncbi:9606">CM</span>
Comparisons of the median and range of each serum biomarker concentration (Table 2), revealed no overlap in the ranges of ANG-1 and the ANG-2:ANG-1 ratio measures in the CM, UM and healthy controls groups in Thai adults, indicating that these markers clearly discriminated the respective groups. However, there was some overlap in the concentration ranges in the Ugandan children with UM the Ugandan children with CM.
###end p 32
###begin title 33
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 84 86 <span type="species:ncbi:9606">UM</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 119 121 <span type="species:ncbi:9606">CM</span>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
Biomarker levels in serum of healthy controls (HC), uncomplicated malaria patients (UM) and cerebral malaria patients (CM) from adult Thai patients and pediatric Ugandan patients.
###end title 33
###begin p 34
Values are presented as median (range).
###end p 34
###begin title 35
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Receiver operating characteristic (ROC) curves indicate that angiopoietin levels discriminate between uncomplicated and cerebral malaria patients
###end title 35
###begin p 36
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">2</xref>
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1B</xref>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 717 726 717 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2B</xref>
###xml 728 735 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 899 908 899 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1B</xref>
###xml 939 948 939 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2B</xref>
###xml 41 43 <span type="species:ncbi:9606">CM</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
ROC curves for the biomarkers, examining CM patients as "cases" and uncomplicated malaria patients as "controls", were plotted and compared to assess the ability of each marker to discriminate between patients with and without cerebral complications (Figure 1&2, Table 3). In the Thai population, ANG-1 and the ANG-2:ANG-1 ratio have an area under the curve (AUC) of 1 (Figure 1B, Table 3) and differ significantly (p<0.001) from that of a chance result (AUC: 0.5). This finding was validated in the geographically, genetically and demographically distinct Ugandan pediatric population, where ANG-1 (AUC: 0.785, p<0.001) and the ANG-2:ANG-1 ratio (AUC: 0.779, p<0.001) were still the best of the biomarkers examined (Figure 2B, Table 3; sICAM-1, data not shown). Although ANG-2 did not have such large AUC values, it showed moderate accuracy as a discriminatory marker in both populations examined (Figure 1B - Thai: AUC = 0.835, p<0.001; Figure 2B - Uganda: AUC = 0.688, p<0.001).
###end p 36
###begin title 37
###xml 51 53 <span type="species:ncbi:9606">UM</span>
###xml 59 61 <span type="species:ncbi:9606">CM</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Area under ROC curve (AUC) for each test comparing UM with CM patients.
###end title 37
###begin p 38
P values are based on the null hypothesis that AUC = 0.5.
###end p 38
###begin p 39
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1B</xref>
###xml 117 126 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2B</xref>
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 185 194 185 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1B</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2B</xref>
###xml 45 47 <span type="species:ncbi:9606">CM</span>
###xml 90 92 <span type="species:ncbi:9606">CM</span>
###xml 279 281 <span type="species:ncbi:9606">CM</span>
Compared to ANG-1 and ANG-2 as biomarkers of CM, previously studied markers of severe and CM such as TNF (Figure 1B, Figure 2B, Table 3) had moderate accuracy as a discriminating test (Figure 1B, AUC: 0.834, p<0.001) in Thai adults; however, TNF was a poor discriminator between CM and uncomplicated malaria in the Ugandan pediatric population (Figure 2B, AUC: 0.557, p = 0.268).
###end p 39
###begin title 40
ANG-1 shows high sensitivity and specificity as a biomarker of cerebral malaria
###end title 40
###begin p 41
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t004">Table 4</xref>
###xml 126 133 <span type="species:ncbi:9606">patient</span>
###xml 225 227 <span type="species:ncbi:9606">CM</span>
###xml 233 235 <span type="species:ncbi:9606">UM</span>
###xml 355 357 <span type="species:ncbi:9606">CM</span>
###xml 363 365 <span type="species:ncbi:9606">UM</span>
###xml 385 393 <span type="species:ncbi:9606">children</span>
###xml 441 443 <span type="species:ncbi:9606">CM</span>
###xml 449 451 <span type="species:ncbi:9606">UM</span>
###xml 682 684 <span type="species:ncbi:9606">CM</span>
###xml 776 778 <span type="species:ncbi:9606">CM</span>
The diagnostic accuracy (sensitivity, specificity, positive and negative likelihood ratios) for each biomarker, stratified by patient population, are reported in Table 4. Based on ROC curve analysis, ANG-1 best discriminated CM from UM. In the Thai population, ANG-1 at a threshold of 21 ng/mL had a sensitivity and specificity of 100% for distinguishing CM from UM, while for Ugandan children ANG-1 (at a cut off of 15 ng/mL) distinguished CM from UM with sensitivity and specificity of 70% and 75%, respectively. Across both populations, using an ANG-1 threshold of 15 ng/mL, the pooled sensitivity (95% CI) was 0.77 (0.67-0.84), specificity 0.82 (0.72-0.88), likelihood ratio of CM given a positive test (ANG-1 below 15 ng/mL) was 4.1 (2.7-6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20-0.42).
###end p 41
###begin title 42
###xml 243 251 <span type="species:ncbi:9606">patients</span>
Optimal cut-off values (95% CI) for each test and sensitivity (SEN), specificity (SPEC), positive likelihood ratio (LR(+)) and negative likelihood ratio (LR(-)) at the chosen cut-off value comparing uncomplicated malaria with cerebral malaria patients.
###end title 42
###begin p 43
significantly different from 1 (p<0.05).
###end p 43
###begin title 44
###xml 30 32 <span type="species:ncbi:9606">CM</span>
The association of ANG-1 with CM is independent of parasite burden and other covariates
###end title 44
###begin p 45
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t001">Table 1</xref>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1176 1183 1176 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t005">Table 5</xref>
###xml 96 98 <span type="species:ncbi:9606">CM</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 223 225 <span type="species:ncbi:9606">CM</span>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 356 364 <span type="species:ncbi:9606">children</span>
###xml 531 533 <span type="species:ncbi:9606">CM</span>
###xml 646 654 <span type="species:ncbi:9606">children</span>
###xml 660 662 <span type="species:ncbi:9606">UM</span>
###xml 690 692 <span type="species:ncbi:9606">CM</span>
###xml 842 849 <span type="species:ncbi:9606">patient</span>
###xml 896 898 <span type="species:ncbi:9606">CM</span>
###xml 1056 1058 <span type="species:ncbi:9606">CM</span>
Although higher parasitemia is generally associated with an increased risk of severe malaria or CM, severe disease can occur in individuals with relatively low peripheral parasitemias. In the Thai population, patients with CM had significantly higher parasitemias than in uncomplicated malaria patients (p<0.001); however, this was not the case in Ugandan children (Table 1). Increased serum cytokine levels may reflect the immune response to increased parasite burdens, rather than being indicative of a clinical syndrome such as CM. In support of this hypothesis, TNF levels were significantly correlated with the parasite burden among Ugandan children with UM (r2 = 0.38, p = 0.004) and CM (r2 = 0.44, p<0.001). In contrast, angiopoietins did not significantly correlate with parasitemia in an analysis stratified by clinical syndrome and patient population, yet were strongly associated with CM, suggesting that they provide diagnostic information independent of measured parasitemia. Furthermore, ANG-1 (but not TNF) was independently associated with CM in a multivariate logistic regression model, adjusting for the potential confounding effects of multiple covariates (Table 5).
###end p 45
###begin title 46
###xml 63 65 <span type="species:ncbi:9606">CM</span>
###xml 74 76 <span type="species:ncbi:9606">UM</span>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
Results of a multivariate logistic regression model to predict CM (versus UM) in two diverse patient populations.
###end title 46
###begin p 47
baseline comparator group.
###end p 47
###begin p 48
###xml 55 57 <span type="species:ncbi:9606">CM</span>
Adjusted odds ratio represents the incremental odds of CM for every unit increase (1 ng/mL) in the ANG-1 level.
###end p 48
###begin title 49
###xml 67 75 <span type="species:ncbi:9606">children</span>
ANG-1 levels and the ANG-2:ANG-1 ratio predict survival in African children with cerebral malaria
###end title 49
###begin p 50
###xml 355 363 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g003">Figure 3</xref>
###xml 75 83 <span type="species:ncbi:9606">children</span>
###xml 89 91 <span type="species:ncbi:9606">CM</span>
###xml 258 260 <span type="species:ncbi:9606">CM</span>
###xml 288 290 <span type="species:ncbi:9606">CM</span>
###xml 321 323 <span type="species:ncbi:9606">CM</span>
###xml 439 441 <span type="species:ncbi:9606">CM</span>
###xml 469 471 <span type="species:ncbi:9606">CM</span>
###xml 503 505 <span type="species:ncbi:9606">CM</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
We examined angiopoietin levels at presentation and subsequent survival in children with CM and observed that ANG-1 levels and the ratio of ANG-2:ANG-1 were related to mortality. Higher ANG-1 levels at presentation were associated with protection from fatal CM (median (range): non-fatal CM 9.1 (0.39 to 38) versus fatal CM 0.39 (0.39 to 4.6), p = 0.027; Figure 3), whereas ANG-2:ANG-1 ratios were higher in those who subsequently died of CM (median (range): non-fatal CM 0.13 (0.01 to 82) versus fatal CM 2.6 (1.4 to 13), p = 0.013). No patients died in the Thai cohort.
###end p 50
###begin title 51
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Angiopoietin-1 levels are associated with clinical outcome in pediatric cerebral malaria patients from Uganda.
###end title 51
###begin p 52
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 85 87 <span type="species:ncbi:9606">CM</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 258 260 <span type="species:ncbi:9606">CM</span>
###xml 274 276 <span type="species:ncbi:9606">CM</span>
Serum concentrations of angiopoietin-1 (ANG-1) were measured in 69 cerebral malaria (CM) patients at presentation and compared to outcome. Higher ANG-1 levels at presentation were associated with protection from fatal cerebral malaria. *p = 0.027, non-fatal CM versus fatal CM (Wilcoxon rank-sum test).
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 550 558 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1</xref>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t002">Tables 2</xref>
###xml 569 569 569 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003"/>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t004">4</xref>
###xml 598 606 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">Figure 2</xref>
###xml 608 616 608 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t002">Tables 2</xref>
###xml 617 617 617 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003"/>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t004">4</xref>
###xml 838 846 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g003">Figure 3</xref>
###xml 906 912 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Yeo1">[33]</xref>
###xml 95 97 <span type="species:ncbi:9606">CM</span>
###xml 242 250 <span type="species:ncbi:9606">children</span>
###xml 377 384 <span type="species:ncbi:9606">patient</span>
###xml 492 494 <span type="species:ncbi:9606">CM</span>
###xml 499 501 <span type="species:ncbi:9606">UM</span>
###xml 576 584 <span type="species:ncbi:9606">children</span>
###xml 713 715 <span type="species:ncbi:9606">CM</span>
###xml 820 828 <span type="species:ncbi:9606">children</span>
###xml 834 836 <span type="species:ncbi:9606">CM</span>
###xml 1133 1141 <span type="species:ncbi:9606">children</span>
This study provides evidence implicating dysregulation of angiopoietins in the pathogenesis of CM and suggests that they may be clinically informative biomarkers of this syndrome. Since the manifestations of severe malaria may differ between children and adults and in varying backgrounds, we measured serum ANG-1 and ANG-2 levels in two geographically and genetically diverse patient and parasite populations and demonstrate that these endothelial regulators were accurate discriminators of CM vs. UM in both settings. In both adults from Thailand (Figure 1; Tables 2-4) and children from Uganda (Figure 2; Tables 2-4), low ANG-1 levels or increased ANG-2:ANG-1 ratios were shown to be informative biomarkers of CM and superior to TNF. Furthermore, ANG-1 levels and the ANG-2:ANG-1 ratios predicted survival in African children with CM (Figure 3). Our findings are in agreement with a recent study by Yeo et al.[33] who reported that ANG-2 levels were higher in Indonesian adults with severe malaria and were better predictors of death than other markers of disease, such as lactate. Our study extends these observations to African children and suggests that the balance between ANG-2 and ANG-1 may be particularly informative with respect to the state of endothelial activation and disease severity.
###end p 54
###begin p 55
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Reyburn1">[34]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Taylor1">[35]</xref>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-1">[1]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Taylor1">[35]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Taylor1">[35]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Beare1">[36]</xref>
###xml 1147 1151 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Beare1">[36]</xref>
###xml 1153 1157 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kochar1">[37]</xref>
###xml 1159 1163 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Kochar2">[38]</xref>
###xml 83 85 <span type="species:ncbi:9606">CM</span>
###xml 218 220 <span type="species:ncbi:9606">CM</span>
###xml 256 258 <span type="species:ncbi:9606">CM</span>
###xml 284 292 <span type="species:ncbi:9606">children</span>
###xml 492 494 <span type="species:ncbi:9606">CM</span>
###xml 553 560 <span type="species:ncbi:9606">patient</span>
###xml 818 820 <span type="species:ncbi:9606">CM</span>
###xml 1042 1050 <span type="species:ncbi:9606">children</span>
###xml 1068 1070 <span type="species:ncbi:9606">CM</span>
###xml 1134 1136 <span type="species:ncbi:9606">CM</span>
###xml 1272 1280 <span type="species:ncbi:9606">patients</span>
###xml 1517 1519 <span type="species:ncbi:9606">CM</span>
No laboratory tests are currently available to definitively confirm a diagnosis of CM, and misdiagnosis may result in increased adverse outcomes [34], [35]. The lack of a reference standard for definitive diagnosis of CM is associated with misdiagnosis of CM, particularly in African children where post-mortem studies have shown approximately 20% of "cerebral malaria" cases were due to other causes [1], [35]. The ability to accurately determine the presence of, or risk for progression to CM in falciparum-infected individuals would be of benefit in patient triage, appropriate clinical management and efficient resource allocation. Fundoscopic examination demonstrating malarial retinopathy has been reported to be a useful pre-mortem discriminator of severe malaria and has been proposed as a diagnostic test for CM [35], [36]. However, indirect fundoscopy has inherent limitations, including requirements for pupil dilation, specialized training and equipment. Furthermore, it is unclear whether fundoscopy can be used to predict which children will progress to CM, and retinopathy does not appear to be a consistent feature of CM in adults [36], [37], [38]. Although the current study did not directly address whether ANG-1 and ANG-2 could be used to predict which patients with uncomplicated disease will progress to cerebral malaria, our results clearly demonstrate that ANG-1 and ANG-2 are sensitive and specific indicators of severe disease that effectively differentiate between uncomplicated malaria and CM.
###end p 55
###begin p 56
###xml 23 25 <span type="species:ncbi:9606">CM</span>
###xml 439 441 <span type="species:ncbi:9606">CM</span>
###xml 471 473 <span type="species:ncbi:9606">CM</span>
An ideal biomarker for CM might be expected to possess a number of logistical, diagnostic/prognostic and therapeutic attributes, including 1) capacity to be easily measured in a readily available specimen such as serum or whole blood by a standardized assay that requires limited specialized equipment and performed with minimal training, 2) reliable detection, with high sensitivity and specificity of individuals with either established CM or at risk of progression to CM, and 3) detection of determinants likely to be involved in the underlying pathogenesis of the disorder (rather than bystander reactions/epiphenomena), thereby providing a metric of the underlying disease process, as well as representing potential therapeutic targets for intervention.
###end p 56
###begin p 57
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figure 1</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">2</xref>
###xml 552 559 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 608 617 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g001">Figures 1</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004912-g002">2</xref>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004912-t003">Table 3</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Dondorp1">[39]</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Dondorp1">[39]</xref>
###xml 1020 1026 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Yeo1">[33]</xref>
###xml 1580 1584 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hunt1">[24]</xref>
###xml 37 39 <span type="species:ncbi:9606">CM</span>
###xml 486 488 <span type="species:ncbi:9606">CM</span>
###xml 1384 1386 <span type="species:ncbi:9606">CM</span>
###xml 1564 1566 <span type="species:ncbi:9606">CM</span>
Despite the growing realization that CM is a complex multisystem disorder, our data suggest that angiopoietins meet several of these criteria and may represent clinically useful biomarkers for this syndrome. Angiopoietins appear to be robust and accessible targets, readily detectable by standard immunoassays in serum or whole blood. ROC curve analysis in both Ugandan pediatric and Thai adult populations indicated that ANG-1 and ANG-2 were highly accurate tests for the detection of CM and its discrimination from uncomplicated disease (Figure 1&2; Table 3), and superior to current markers, such as TNF (Figures 1&2; Table 3) and sICAM-1 (data not shown). In this study, serum TNF levels were positively correlated with parasitemia, whereas angiopoietin levels were not. Although peripheral parasitemia is a limited marker of disease burden in malaria, it does not account for total parasite burden, which includes sequestered parasites [39]. Total parasite biomass can be estimated using plasma HRP-2 [39], and Yeo et al.[33] have recently reported that ANG-2 levels were positively correlated with this marker of parasite burden. However, the different relationship between the angiopoietins, TNF and parasitemia in our study suggests that higher levels of TNF may relate to parasitemia whereas the change in ANG-2:ANG-1 ratio may be related to the overall clinical syndrome of CM. This may be an important distinction given the growing body of evidence supporting an essential role for host-mediated immunopathology and tissue injury in the pathogenesis of CM (reviewed in [24]).
###end p 57
###begin p 58
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Yeo1">[33]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Looareesuwan1">[40]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Warrell1">[41]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Brown1">[22]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Brown2">[23]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hunt1">[24]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Medana1">[25]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Tripathi1">[26]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Fiedler1">[27]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Hunt1">[24]</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 72 74 <span type="species:ncbi:9606">CM</span>
###xml 301 303 <span type="species:ncbi:9606">CM</span>
###xml 344 346 <span type="species:ncbi:9606">CM</span>
###xml 387 389 <span type="species:ncbi:9606">CM</span>
###xml 1219 1221 <span type="species:ncbi:9606">CM</span>
Our observations that ANG-1 and ANG-2 are dysregulated in patients with CM, supports the hypothesis that they may be involved in the pathogenesis of this syndrome. As key regulators of endothelial integrity, there are several mechanisms by which angiopoietins may contribute to the pathophysiology of CM. Although the role of BBB disruption in CM remains controversial [33], [40], [41], CM is characterized by parasite sequestration to CAMs, dysregulated inflammation, and endothelial cell and BBB dysfunction [22], [23], [24], [25], [26]. The endothelium is a large and continuous vascular organ whose state of activation is dependent upon the angiopoietin-Tie2 system [27]. ANG-1 maintains endothelial quiescence and intact tight junctions important for preventing vascular permeability especially across the BBB. ANG-2, stored in endothelial cell granules, may be rapidly released resulting in endothelial activation, augmented inflammation, loosening of endothelial cell junctional complexes, and upregulation of cerebral endothelial adhesion molecules such as ICAM-1 to which parasitised erythrocytes adhere. Increases in BBB permeability have been proposed to be one of the earliest events in the pathogenesis of CM [24]. Therefore dysregulation of angiopoietins, as occurs when ANG-2 levels rise and ANG-1 levels fall, may reflect one of the pivotal or initiating events in the syndrome.
###end p 58
###begin p 59
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Medana1">[25]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Mei1">[42]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Gubler1">[43]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Marty1">[44]</xref>
###xml 267 273 <span type="species:ncbi:9606">humans</span>
It will be important to dissect the putative mechanisms by which angiopoietins may contribute to malaria pathogenesis in animal models where endothelial and BBB dysfunction and vascular leak are central features of disease [25]. If confirmed by additional studies in humans and clinically relevant animal models, advanced therapies to preserve regulated angiogenic responses, for example by delivering recombinant ANG-1 to restore endothelial cell quiescence, can be examined to determine if they offer clinical benefit as they have in other models of life-threatening infectious disease [42]. It will also be of interest to determine if ANG-2/ANG-1 imbalance will predict outcome in other severe infectious and inflammatory disease states that impact vascular integrity and permeability such as dengue and other viral hemorrhagic fevers, rickettsial infections, toxic shock syndrome and sepsis [43], [44].
###end p 59
###begin p 60
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Taylor1">[35]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004912-Beare1">[36]</xref>
###xml 198 200 <span type="species:ncbi:9606">CM</span>
###xml 543 545 <span type="species:ncbi:9606">CM</span>
###xml 674 676 <span type="species:ncbi:9606">CM</span>
###xml 861 863 <span type="species:ncbi:9606">CM</span>
###xml 944 946 <span type="species:ncbi:9606">CM</span>
One limitation of our study is the relatively small sample sizes, particularly in the Thai population. The sensitivity and specificity of ANG-1 levels and the ANG-2/ANG-1 ratio for the diagnosis of CM was 100% in the Thai population and somewhat lower in the Ugandan pediatric cohort. It will be important to confirm and extend our observations and further assess performance and specificity in larger prospective clinical trials, especially those assessing malarial retinopathy and autopsy studies with histopathologically confirmed cases of CM [35], [36]. Another limitation is that this study focused on the utility of angiopoietin levels in the diagnosis and outcome of CM. Future prospective studies will be required to assess the value of serum angiopoietin levels in predicting progression and outcome of severe or cerebral disease and in distinguishing CM from coma of other causes. With respect to the specificity of angiopoietins for CM versus other life-threatening infections, it is important to note that biomarkers such as angiopoietins are more likely to provide clinically relevant information pertaining to the mechanism and severity of the underlying disease process and the need for critical care triage/referral, and are not expected to be pathogen-specific. Therefore, they will be expected to complement, rather than replace, conventional pathogen diagnosis (for example, microscopy, HRPII or pLDH detection for malaria) and enhance triage and clinical management.
###end p 60
###begin p 61
###xml 210 212 <span type="species:ncbi:9606">CM</span>
###xml 272 280 <span type="species:ncbi:9606">children</span>
In summary, these data suggest that the dysregulation of angiogenic factors may be involved in the pathogenesis of cerebral malaria and that serum ANG-1 and ANG-2 levels are accurate biomarkers to discriminate CM from uncomplicated disease and predict survival in African children with cerebral involvement.
###end p 61
###begin p 62
###xml 123 131 <span type="species:ncbi:9606">patients</span>
We thank our study teams of medical officers, nurses, data entry clerks and office staff members for their efforts and the patients and their families for their participation in the study.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Severe and complicated malaria. World Health Organization.
###end article-title 64
###begin article-title 65
Imported malaria: prospective analysis of problems in diagnosis and management.
###end article-title 65
###begin article-title 66
###xml 29 37 <span type="species:ncbi:9606">children</span>
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.
###end article-title 66
###begin article-title 67
###xml 48 69 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The global distribution of clinical episodes of Plasmodium falciparum malaria.
###end article-title 67
###begin article-title 68
###xml 38 46 <span type="species:ncbi:9606">children</span>
Severe falciparum malaria in Gabonese children: clinical and laboratory features.
###end article-title 68
###begin article-title 69
###xml 68 76 <span type="species:ncbi:9606">children</span>
Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda.
###end article-title 69
###begin article-title 70
Predictors of a fatal outcome following childhood cerebral malaria.
###end article-title 70
###begin article-title 71
###xml 50 58 <span type="species:ncbi:9606">children</span>
Indicators of life-threatening malaria in African children.
###end article-title 71
###begin article-title 72
###xml 71 92 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
###end article-title 72
###begin article-title 73
###xml 46 54 <span type="species:ncbi:9606">children</span>
Tumor necrosis factor and disease severity in children with falciparum malaria.
###end article-title 73
###begin article-title 74
###xml 95 116 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.
###end article-title 74
###begin article-title 75
###xml 75 96 <span type="species:ncbi:5833">Plasmodium falciparum</span>
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.
###end article-title 75
###begin article-title 76
###xml 150 158 <span type="species:ncbi:9606">children</span>
###xml 171 192 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls.
###end article-title 76
###begin article-title 77
###xml 30 38 <span type="species:ncbi:9606">children</span>
Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
###end article-title 77
###begin article-title 78
Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.
###end article-title 78
###begin article-title 79
Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity.
###end article-title 79
###begin article-title 80
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.
###end article-title 80
###begin article-title 81
###xml 51 59 <span type="species:ncbi:9606">children</span>
Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma.
###end article-title 81
###begin article-title 82
von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation.
###end article-title 82
###begin article-title 83
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 81 102 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 106 114 <span type="species:ncbi:5855">P. vivax</span>
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.
###end article-title 83
###begin article-title 84
###xml 77 98 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.
###end article-title 84
###begin article-title 85
###xml 47 52 <span type="species:ncbi:9606">human</span>
Evidence of blood-brain barrier dysfunction in human cerebral malaria.
###end article-title 85
###begin article-title 86
###xml 61 69 <span type="species:ncbi:9606">children</span>
Blood-brain barrier function in cerebral malaria in Malawian children.
###end article-title 86
###begin article-title 87
Immunopathogenesis of cerebral malaria.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cerebral malaria and the blood-brain barrier.
###end article-title 88
###begin article-title 89
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers.
###end article-title 89
###begin article-title 90
Angiopoietins: a link between angiogenesis and inflammation.
###end article-title 90
###begin article-title 91
###xml 89 95 <span type="species:ncbi:9606">humans</span>
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.
###end article-title 91
###begin article-title 92
###xml 33 41 <span type="species:ncbi:9606">children</span>
Admission angiopoietin levels in children with septic shock.
###end article-title 92
###begin article-title 93
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory medicators.
###end article-title 93
###begin article-title 94
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
###end article-title 94
###begin article-title 95
###xml 54 62 <span type="species:ncbi:9606">children</span>
Low levels of RANTES are associated with mortality in children with cerebral malaria.
###end article-title 95
###begin article-title 96
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.
###end article-title 96
###begin article-title 97
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study.
###end article-title 97
###begin article-title 98
Differentiating the pathologies of cerebral malaria by postmortem parasite counts.
###end article-title 98
###begin article-title 99
Malarial retinopathy: a newly established diagnostic sign in severe malaria.
###end article-title 99
###begin article-title 100
Ophthalmoscopic abnormalities in adults with falciparum malaria.
###end article-title 100
###begin article-title 101
Prognostic significance of eye changes in cerebral malaria.
###end article-title 101
###begin article-title 102
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2.
###end article-title 102
###begin article-title 103
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Magnetic resonance imaging of the brain in patients with cerebral malaria.
###end article-title 103
###begin article-title 104
###xml 53 58 <span type="species:ncbi:9606">human</span>
Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis.
###end article-title 104
###begin article-title 105
###xml 47 51 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1.
###end article-title 105
###begin article-title 106
Dengue and dengue hemorrhagic fever.
###end article-title 106
###begin article-title 107
Viral hemorrhagic fevers.
###end article-title 107
###begin p 108
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The University Health Network holds intellectual property related to the role of angiogenic factors in the pathogenesis of infectious disease. The authors report no conflict of interest with respect to this manuscript.
###end p 108
###begin p 109
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a CIHR Team Grant in Malaria (KCK), operating grant MT-13721(KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK, WCL), the NIH Fogarty International Center (grant R21 TW-006794, CCJ), and The McLaughlin Centre for Molecular Medicine (KCK, WCL). The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
###end p 109

